PolitiKit

The development of a Canadian Manufacturing Strategy, as it relates to the competitiveness of Canada’s automotive manufacturing industry.

Discussions on North American trade.

Communication regarding transportation, vehicle electrification and reducing carbon emissions, as it relates to the government's light-duty Zero Emission Vehicle (ZEV) sales mandate regulation for new vehicle purchases and other related policies and programs, including ZEV charging and refueling infrastructure development.

Communication regarding trade related issues, including free trade agreements such as the Canada-US-Mexico Free Trade Agreement, as it relates to the auto industry.

Science & Technology Strategy - promotion of enhanced measures to increase research in science and technology

Brain Canada Foundation is seeking a top-up to its current funding to support the development and application of AI to accelerate research, advance our understanding of the brain, and identify solutions for brain diseases and disorders.

Monitor all developments to the Tobacco Act and its regulations

Advocating for increased investment toward tuberculosis elimination, specifically through the creation of a national tuberculosis elimination strategy.

Advocating spending priorities related to the dissemination of Canada's Official Development Assistance envelope to ensure that aid is targetted at initiatives that serve the world's poorest.

Advocating for institutional infrastructure investments from various federal programs.

Advocate for increased and continued representation of disability sector supports in annual budget. Seek additional funding for Disability Benefits, Disability Tax Credit, Enabling Accessibility Fund.

Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations

Free trade agreements as they relate to the biopharmaceutical industry

Establish accountability with the federally financed Canadian Agency for Drugs and Technologies in Health (CADTH)

Addressing administrative burden: Administrative burden consistently ranks as a top concern for family physicians. This time comes in the way of providing patient care. One of the significant sources of administrative burden for family physicians is filling out federal health forms.

Support family doctors with teams, as that is a key enabler to providing high quality primary care

Invest in family medicine by adding new family doctors and directing funding to expand training, have fair compensation, and other recruitment/retention measures.

Support family doctors with teams, as that is a key enabler to providing high quality primary care

Advocating for institutional infrastructure investments from various federal programs.

PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories.

TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector and the means through which advancements can be foreseen and managed.

ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, the development of a Federal Disability Benefit, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, providing clarity and guidance on federal forms, and advocacy on discontinuing the requirement that employees present sick notes to their employers.

PHYSICIAN PARLIAMENTARIAN CAUCUS: advocate for the formation of a Physician Parliamentarian Caucus as a means of examining deficiencies in the health care system and proposing solutions.

BUDGET: Provide CMA’s perspective on the Government of Canada’s budget, particularly as it relates to modernizing Canada’s health care system by enhancing efficiency, driving innovation, and promoting equitable access to care.

FEDERAL HEALTH FUNDING FOR A NEW PRIMARY CARE ACCESS FUND: Recommendation for a funding commitment to ensure that every Canadian has access to a family doctor or primary care team.

INDIGENOUS HEALTH AND RECONCILIATION WITH INDIGENOUS PEOPLES: Implementation of the Calls to Action of the Truth and Reconciliation Commission, including addressing the ongoing structural inequities that marginalize Indigenous Peoples, advancing the inclusion of Indigenous Peoples in societal systems and sectors, including health systems, and committing to collaborative and respectful relationships with Indigenous patients and communities. The CMA is also advocating to increase trust between Indigenous patients and health care providers, and to eliminate racism, inequitable access to care, and the ongoing harm caused to those within Canada’s health care system.

INTEGRATED HEALTH HUMAN RESOURCES: Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care.

PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories.

ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, and advocacy on discontinuing the requirement that employees present sick notes to their employers.

PHYSICIAN PARLIAMENTARIAN CAUCUS: advocate for the formation of a Physician Parliamentarian Caucus as a means of examining deficiencies in the health care system and proposing solutions.

TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector and the means through which advancements can be foreseen and managed.

BUDGET: Provide CMA’s perspective on the Government of Canada’s budget, particularly as it relates to modernizing Canada’s health care system by enhancing efficiency, driving innovation, and promoting equitable access to care.

FEDERAL HEALTH FUNDING FOR A NEW PRIMARY CARE ACCESS FUND: Recommendation for a funding commitment to ensure that every Canadian has access to a family doctor or primary care team.

Advancing a National Children's Strategy to advance child and youth health and well-being outcomes.

Advancing measures to meaningfully improve child and youth health and well-being outcomes through initatives to "right-size" children's healthcare.

Aging at Home Benefit.

Canada Labour Code, as it relates to employment insurance and job-protected leave.

National Caregiving Strategy

Controlled Products Regulations, as it relates to implementing the Globally Harmonized System in Canada.

Food and Drugs Act and regulations, as it relates to nicotine replacement products

Access to medication - expanding the range of medications covered by various insurance plans, and the number of Canadians able to access and afford medication. This includes a national pharmaceutical strategy.

Canada Health Act and regulations, as it relates to long-term, home and palliative care.

Health Canada's tobacco control program and policies related to tobacco and vaping products, including sustaining government funding levels, and implementation of effective programs and policies.

Funding for programs to be operated by the Canadian Cancer Society to advance cancer control.

Canada Health Transfer - health system funding transfer and agreements intended for provinces/territories to support the delivery of healthcare services, including cancer care services and palliative care.

Employment Insurance special benefit programs, asking the federal government to improve these benefits by expanding eligibility.

UN Declaration on the Prevention and Control of Non-Communicable Diseases, as it pertains to cancer control, including the development of a Global Coordination Mechanism; increased federal investments in prevention initiatives; and policy changes as it relates to tobacco control, healthy living, and access to screening and treatment, as identified in the Declaration.

Health Human Resources and Coalition for Action for health care workers.

Equitable and timely access to cancer screening.

Legislation/regulation of electronic cigarettes including use, marketing and all other aspects.

Access to palliative care, as it relates to programs offered through Health Canada, Indigenous Services Canada, Immigration, Refugees, and Citizenship Canada, the Department of National Defence, and Employment and Social Development Canada.

Patent Act, as it relates to the use of patents for international humanitarian purposes to address public health problems.

Framework Convention on Tobacco Control, including protocols, guidelines and implementation.

Data as it relates to all health and cancer data policy, planning and outcomes.

Non-Smokers' Health Act, including implementation and enforcement.

Safe Long-Term Care Act.

First Nations Goods and Services Tax Act and regulations, as it relates to the taxation of tobacco products.

Tobacco and Vaping Products Act and regulations, including ingredients, promotion, packaging/labelling, product regulation, reporting and enforcement and any other aspect.

Food and Drugs Act and regulations, as it relates to alcohol warning labels

Trade agreements as they relate to tobacco control.

Excise Act, 2001 and regulations, as it relates to contraband and the taxation of tobacco and vaping products.

Canadian Institutes of Health Research as it relates to continued federal funding & long term investment in health research.

Canadian Partnership Against Cancer, as it relates to continued federal funding & long term investment in health research through Canadian Institutes of Health Research.

Measures and funding for the charitable sector generally.

Food and Drugs Act and regulations, as it relates to restricting the advertising to children of foods high in sodium, sugars and saturated fat.

Encouraging regulatory, policy, program, or financial support for carbon capture, utilization, and storage (CCUS) infrastructure.

Developing regulatory and fiscal framework for enable ammonia exports of Canada's West Coast to overseas markets. Advocacy also includes infrastucture investments to facilitate this emerging sector.

Working with Global Affairs Canada (GAC - including Invest in Canada), Innovation, Science and Industry (ISI), Western Economic Diversification (WD), and Natural Resources Canada (NRCan) to jointly promote investment opportunities in Alberta's Industrial Heartland.